Treatment and Management Options forReversible Airway Disease
The American Journal of Managed Care
This supplement to contains information on the treatmentand management of reversible airway diseases, such as chronic obstructive pulmonary disease and asthma.
Faculty
Campion Quinn, MD, FACP, MHA
President
Campion Quinn and Associates LLC
Medical Consultants
Shellie K. Schoening, MBA, PharmD, RPh
Assistant Clinical Professor of Pharmacy Practice
School of Pharmacy and Allied Health Professions
Creighton University
Vice President, Clinical Programs
Pharmaceutical Technologies Inc
National Pharmaceutical Services
Omaha, Nebraska
Grant H. Skrepnek, PhD, RPh
Assistant Professor
Department of Pharmaceutical Sciences
Investigator, Center for Health Outcomes and
Pharmacoeconomic Research
The University of Arizona
College of Pharmacy
Tucson, Arizona
Stan V. Skrepnek, MD
Primary Care Physician
East Texas Physicians Alliance LLP
Palestine, Texas
Disclosure Statement
In accordance with the ACCME and the ACPE, participants for this activity have completed a conflict-of-interestdisclosure statement.
In compliance with the Health Insurance Portability and Accountability Act standards, no presentations inthis CME/CE activity shall disclose the names or other unique identifiers of patients referenced without asigned waiver from the identified patient.
The American Journal of Managed Care
It is the policy of to have all faculty who participate in programssponsored by corporate organizations disclose any real or apparent conflicts of interest.
The following participant has declared the following relationships with corporate organizations:
The following participants have declared no financial affiliations with any corporate organizations:
The American Journal of Managed Care
Signed disclosures are on file at the offices of , Jamesburg, New Jersey.